Heat Biologics Inc. (NASDAQ: HTBX) open the trading on September 11, 2020, with a bit cautious approach as it glided -2.65% to $1.10. During the day, the stock rose to $1.10 and sunk to $1.03 before settling in for the price of $1.13 at the close. Taking a more long-term approach, HTBX posted a 52-week range of $0.19-$4.30.
Meanwhile, its Annual Earning per share during the time was 49.50%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 33.20%. This publicly-traded company’s shares outstanding now amounts to $87.93 million, simultaneously with a float of $75.53 million. The organization now has a market capitalization sitting at $167.90 million. At the time of writing, stock’s 50-day Moving Average stood at $1.6784, while the 200-day Moving Average is $0.8315.
It is imperative to bring your focus towards the efficiency factor of the conglomerate that has a total of 36 employees. It has generated 84,697 per worker during the last fiscal year. Meanwhile, its income per employee was -556,044. The stock had 96.00 Receivables turnover and 0.05 Total Asset turnover. For the Profitability, stocks operating margin was -636.11 and Pretax Margin of -667.07.
Heat Biologics Inc. (HTBX) Ownership Facts and Figures
Sometimes it helps to make our mind if we keep our tabs on how bigger investors are working with the stock of the Biotechnology industry. Heat Biologics Inc.’s current insider ownership accounts for 6.04%, in contrast to 13.00% institutional ownership.
Heat Biologics Inc. (HTBX) Earnings and Revenue Records
So, what does the last quarter earnings report of the company that was made public on 6/29/2020 suggests? It has posted -$0.05 earnings per share (EPS) beating the forecaster’s viewpoint (set at -$0.09) by $0.04. This company achieved a net margin of -656.51 while generating a return on equity of -91.28. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.04 per share during the current fiscal year.
Heat Biologics Inc.’s EPS increase for this current 12-month fiscal period is 33.20% and is forecasted to reach -0.22 in the upcoming year.
Heat Biologics Inc. (NASDAQ: HTBX) Trading Performance Indicators
Let’s observe the current performance indicators for Heat Biologics Inc. (HTBX). It’s Quick Ratio in the last reported quarter now stands at 7.70. The Stock has managed to achieve an average true range (ATR) of 0.18. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 47.97.
In the same vein, HTBX’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -0.45, a figure that is expected to reach -0.04 in the next quarter, and analysts are predicting that it will be -0.22 at the market close of one year from today.
Technical Analysis of Heat Biologics Inc. (HTBX)
[Heat Biologics Inc., HTBX] recent stats showed that its last 5-days Average volume was poorer than the volume it posted in the year-ago period. During the previous 9 days, stock’s Stochastic %D was recorded 50.46% While, its Average True Range was 0.1834.
Raw Stochastic average of Heat Biologics Inc. (HTBX) in the period of the previous 100 days is set at 15.79%, which indicates a major fall in contrast to 30.56% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 120.55% that was lower than 155.91% volatility it exhibited in the past 100-days period.